Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists
1997

Patient perceptions of chemotherapy side-effects and the impact of 5HT3 antagonists

Sample size: 181 publication Evidence: moderate

Author Information

Author(s): M de Boer-Dennert, R de Wit, PIM Schmitz, J Djontono, V v Beurden, G Stoter, J Verweijl

Primary Institution: Rotterdam Cancer Institute (Daniel den Hoed Kliniek) and University Hospital, Rotterdam, The Netherlands

Hypothesis

The study aims to evaluate the impact of 5HT3 antagonists on patient perceptions of the side-effects of chemotherapy.

Conclusion

Despite the use of 5HT3 antagonists, nausea and vomiting remain the most distressing side-effects of chemotherapy for patients.

Supporting Evidence

  • Nausea and vomiting were ranked as the first and third most distressing side-effects of chemotherapy.
  • 80% of patients experienced nausea and 57% experienced vomiting.
  • Hair loss was more distressing for women compared to men.
  • Constipation was ranked as a new distressing side-effect compared to previous studies.

Takeaway

Patients undergoing chemotherapy still find nausea and vomiting very distressing, even with new medications that help reduce these side-effects.

Methodology

Patients ranked their side-effects in order of distress using a questionnaire based on a previous survey.

Potential Biases

Health care workers may overestimate the effectiveness of antiemetic treatments based on acute emesis data.

Limitations

The study may not fully capture the long-term effects of chemotherapy on patient perceptions.

Participant Demographics

181 evaluable patients, 101 male and 80 female, mean age 50 years (range 18-78).

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication